Results for “”

Entry Author Date Location
Bio Roundup: Remdesivir Data, Erasca’s $200M, a New FDA Nod & More 05/01/20 National
Podcast: How San Diego is Building a Biotech Ecosystem – Genomics & Precision Medicine Experts Weigh in 04/30/20 National
BridgeBio’s Pipeline Expansion Continues as Portfolio’s Milestones Approach 04/30/20 San Francisco
Adicet Aims to Advance CAR-T Therapies in Reverse Merger with resTORbio 04/29/20 Boston
Supernus Makes a Parkinson’s Play With $300M Deal for US WorldMeds Drugs 04/29/20 National
Taysha Launches With $30M to Bring Gene Therapy to CNS Disorders 04/29/20 Texas
At Rome Therapeutics, Kapeller Aims to Turn “Junk” Into New Drugs 04/28/20 Boston
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill 04/27/20 San Diego
Erasca Lands $200M Mega-Round to Move Cancer Programs to the Clinic 04/27/20 San Diego
ADC Therapeutics Resubmits IPO to Fuel Cancer Drug Filing, Launch Plans 04/27/20 New York
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More 04/24/20 National
Drug Review Times Not Shortened Much by Single Expedited Review Designation 04/24/20 National
ORIC Pharma Gets $120M in IPO to Advance Drug-Resistant Cancer Therapies 04/24/20 San Francisco
Nitrome Bio Bags $38M to Prep Parkinson’s Program for the Clinic 04/23/20 San Francisco
Affinivax Lands $120M to Take MAPS Tech Into New Vaccine Territory 04/23/20 Boston
Life Science a VC Bright Spot in Q1, But Startups May Soon Struggle 04/23/20 National
Biogen Pushes Finalized Filing for Alzheimer’s Drug to Third Quarter 04/22/20 Boston
Immunomedics Triple Negative Breast Cancer Drug Wins Early FDA Nod 04/22/20 New York
Synthorx’s Shawver Joins Silverback Therapeutics as New Top Exec 04/22/20 Seattle
Why 2020 Is Pivotal for Microbiome Drug R&D (Or Maybe 2021, Given COVID-19) 04/22/20 National
BARDA Director Rick Bright Moves to NIH to Head COVID-19 Testing R&D 04/21/20 National
Cara Therapeutics Itching Drug Scratches Off Goals of Phase 3 Test 04/21/20 New York
New COVID-19 Special Reports Explore Clinical Research During the Pandemic 04/21/20 Boston
War Paint to Bone Paint: MIT Spinout Aims to Transform Regenerative Meds 04/21/20 Boston
Unlearn Adds $12M for “Digital Twins” That Accelerate Clinical Trials 04/20/20 San Francisco
FDA Approves Incyte Drug, First Ever for Rare Bile Duct Cancer 04/20/20 National
Seattle Genetics Gets Early FDA Nod for Breast Cancer Combo Drug 04/18/20 Seattle
COVID-19 Vax Efforts Aim to Balance Speed, Efficacy in Race to Market 04/17/20 National
Lantern Pharma IPO File Illuminates Plan to “Rescue” Failed Cancer Drugs 04/17/20 Texas
Bio Roundup: Alnylam’s Billions, COVID-19 Vaccines, Moma Debuts & More 04/17/20 National
Page 3 of 1966 « previous page · next page »